CARR EDWARD Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$142,975.01

Insider Activity of CARR EDWARD

According to the SEC Form 4 filings, CARR EDWARD, being in a position of

  1. CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 63682 shares for $5.59M,
    over all time since 2026-03-12, has bought 0 shares, and sold 63682 shares for $5.59M.

Biography of CARR EDWARD

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,587,1402100

Comparison of Insiders on Amount of Buys and Sells

2026-09-17SaleDianthus Therapeutics, Inc.
DNTH
CHIEF ACCOUNTING OFFICER
20,000
0.0358%
$101.38$2.03M-18.48%
2026-03-12SaleDianthus Therapeutics, Inc.
DNTH
CHIEF ACCOUNTING OFFICER
43,682
0.1224%
$81.49$3.56M+11.37%
2021-10-08SaleAbeona Therapeutics Inc.
ABEO
Chief Financial Officer
29,122
0.0309%
$1.05$30,596-74.74%
2021-04-05SaleAbeona Therapeutics Inc.
ABEO
Chief Accounting Officer
35,000
0.0352%
$1.80$62,846-45.41%
2021-04-01SaleAbeona Therapeutics Inc.
ABEO
Chief Accounting Officer
20,445
0.0211%
$1.85$37,866-40.86%
2020-03-19SaleAbeona Therapeutics Inc.
ABEO
Chief Accounting Officer
6,446
0.0071%
$1.81$11,667+25.84%
Total: 6
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.